How do you address biosafety considerations for engineered organisms?

Biosafety for engineered organisms requires comprehensive risk assessment. Risk evaluation: considers organism pathogenicity, inserted gene functions, environmental release potential, and competitive fitness. Containment strategies: physical (biosafety cabinets, negative pressure), biological (auxotrophy, kill switches, genetic safeguards), and procedural (training, SOPs). Genetic safeguards include: conditional lethality (toxin-antitoxin systems), metabolic dependencies on synthetic amino acids (XNA), genetic instability of key functions, and kill switches (responsive to environmental signals). Regulatory compliance: IBC approval, biosafety levels appropriate to risk, EPA/USDA considerations for environmental release. Risk assessment documentation includes hazard identification, exposure assessment, and risk management plan. Dual-use research concerns require additional oversight. Emerging frameworks address gain-of-function and synthetic genome research.